Nova Satra Dx is committed to empowering patients and physicians through the research, development and commercialisation of blood-based tests that provide accurate and rapid detection of cancer. In 2019, Nova Satra Dx merged with INEX to form INEX Innovate, which focuses on addressing the unmet need for faster and more accurate diagnostics testing and precision health care for Asian women. The merger creates Asia’s first FemTech company with a strong portfolio of intellectual property comprising more than 45 key patents and nine trademarks worldwide. The company’s women’s reproductive health solutions have been commercialised in multiple markets across Asia-Pacific and are witnessing growing sales in existing markets whilst expanding into new ones such as Indonesia and Bangladesh.